OPTIMIZED MESSENGER RNA

Details for Australian Patent Application No. 2002215389 (hide)

Owner TRANSKARYOTIC THERAPIES, INC.

Inventors SELDON, Richard, F.; MILLER, Allan, M.; TRECO, Douglas, S.

Pub. Number AU-A-2002215389

PCT Pub. Number WO2002/064799

Priority 09/686,497 11.10.00 US

Filing date 11 October 2001

Wipo publication date 28 August 2002

International Classifications

C12N 015/67 Mutation or genetic engineering - General methods for enhancing the expression

C07H 021/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 014/745 Peptides having more than 20 amino acids

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-A-2002215389

29 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002215390

2002215388